T-Cell Response to Gluten in Patients With HLA-DQ2.2 Reveals Requirement of Peptide-MHC Stability in Celiac Disease

This publication has 29 references indexed in Scilit:

• Tissue-mediated control of immunopathology in coeliac disease
  Nature Reviews Immunology, 2009
• Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation
  Nature Immunology, 2009
• Refining the Rules of Gliadin T Cell Epitope Binding to the Disease-Associated DQ2 Molecule in Celiac Disease: Importance of Proline Spacing and Glutamine Deamidation
  The Journal of Immunology, 2005
• The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses
  Proceedings of the National Academy of Sciences, 2003
• Hla types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the european genetics cluster on celiac disease
  Human Immunology, 2003
• The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides
  Gastroenterology, 2002
• Gliadin Specific, HLA DQ2‐Restricted T Cells are Commonly Found in Small Intestinal Biopsies from Coeliac Disease Patients, but not from Controls
  Scandinavian Journal of Immunology, 1997
• T cells from the small intestinal Mucosa of a DR4, DQ7/DR4. DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8
  Human Immunology, 1994
• Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.
  The Journal of Experimental Medicine, 1993
• Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer.
  The Journal of Experimental Medicine, 1989